Chemicals and life sciences sector again attracts most foreign investment

With 40 investment projects, providing 877 new jobs and a total investment amount of more than 408 million euros, the chemicals and life sciences sector was again number 1 in Flanders in 2020 for attracting foreign investments. This is evident from figures from FIT (Flanders Investment & Trade). Due to the difficult economic context, the […]

Univercells builds two production plants in Jumet

The biotechnology company Univercells is setting up its subsidiary Exothera in Jumet, on the former site of the IT company Systemat, to offer complete development and manufacturing services for viral vectors for the development of vaccines and gene therapies. Exothera relies on the use of innovative production platforms to reduce costs and make these treatments […]

Soudal doubles production capacity in Turnhout with new ‘factory of the future’

Soudal, an expert in chemical building materials, is building a new factory for adhesives and mastics that will double the current production capacity in Turnhout. The advanced production facility – with an investment of 40 million euros – will cover more than 20,000 m² and will operate with a fully automatic process. There is no […]

Janssen Pharmaceutica invests in unique European production site for cell therapy in Ghent

Later this year, Janssen Pharmaceutica will start building a production facility for CAR-T therapy in the Tech Lane science park in Zwijnaarde. It will be the only European branch of the pharmaceutical company where this type of innovative cell therapy for blood cancers will be developed. The state-of-the-art complex, which will cover some 26,000 square […]

GSK continues to invest heavily in Belgium at its sites in Wavre and Rixensart

The British pharmaceutical company GSK continues to invest in its production site in Wavre and its research and development site in Rixensart. In Wavre, the largest vaccine production centre in the world, the €330 million investment announced in March 2021 includes the creation of a new freeze-drying unit. GSK wants to make its Wavre site […]

UCB invests in a bioproduction plant in Braine-l’Alleud

To support the launch of a new generation of products, UCB, the biopharmaceutical company specialized in neurology and immunology, is investing 300 million euros in the construction of an ultra-modern biological production plant at its site in Braine-l’Alleud. The plant should be operational in 2024 and should create 150 direct jobs. This new infrastructure is […]

Kaneka Eurogentec’s new state-of-the-art production unit is up and running

In July 2020, Kaneka biotech Eurogentec received GMP accreditation for its state-of-the-art facility for the large-scale production of next-generation drugs, such as DNA-based vaccines against coronavirus and gene therapy treatments. This investment creates new job opportunities. Kaneka Eurogentec is one of the world’s leading biomanufacturers of GMP (Good Manufacturing Practice) plasmid DNA for gene and […]